About Cell IDx
Cell IDx is a company based in San Diego (United States) founded in 2012 was acquired by Leica Biosystems in November 2022.. Cell IDx has raised $1.34 million across 2 funding rounds from investors including Leica Biosystems. Cell IDx offers products and services including Tissue Processors, Digital Pathology Scanners, and IHC Primary Antibodies. Cell IDx operates in a competitive market with competitors including HYCOR BioMedical, Exagen, Kypha, Lophius Biosciences and SmartHealth, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cell Idx, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.34 M (USD)
in 2 rounds
-
Latest Funding Round
$1.34 M (USD), Seed
Dec 21, 2021
- Investors
-
Employee Count
Employee Count
-
Acquired by
Leica Biosystems
(Nov 08, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cell IDx
Cell IDx offers a comprehensive portfolio of products and services, including Tissue Processors, Digital Pathology Scanners, and IHC Primary Antibodies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Devices for preparing tissue samples in diagnostics
Scanners for high-quality slide imaging in research
Antibodies for immunohistochemistry applications
Unlock access to complete
Unlock access to complete
Funding Insights of Cell IDx
Cell IDx has successfully raised a total of $1.34M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.34 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $1.3M
-
First Round
First Round
(06 May 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Seed - Cell IDx | Valuation |
investors |
|
| May, 2016 | Amount | Grant - Cell IDx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cell IDx
Cell IDx has secured backing from 1 investor. Prominent investors backing the company include Leica Biosystems. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cell IDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cell IDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cell Idx Comparisons
Competitors of Cell IDx
Cell IDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, Kypha, Lophius Biosciences and SmartHealth, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| domain | founded_year | HQ Location |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| domain | founded_year | HQ Location |
Diagnostic biomarker tests for inflammation and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
T-cell-based diagnostics for infectious and immune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostics for vascular, metabolic, and oncological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics kits, instruments, and software are developed and manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cell IDx
When was Cell IDx founded?
Cell IDx was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Where is Cell IDx located?
Cell IDx is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is Cell IDx a funded company?
Cell IDx is a funded company, having raised a total of $1.34M across 2 funding rounds to date. The company's 1st funding round was a Grant of $507.46K, raised on May 06, 2016.
What does Cell IDx do?
Cell IDx was founded in 2012 and is based in San Diego, United States. Operations focus on the biotechnology sector, where highly sensitive reagents for research and clinical immunohistochemistry, as well as other immunoassays, are developed. Products such as ultrapolymer enzyme conjugates, ultraplex immunohistochemistry kits, and ancillary reagents are offered. Biomolecules are also conjugated and immobilized with emphasis on high yields and activity retention.
Who are the top competitors of Cell IDx?
Cell IDx's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
What products or services does Cell IDx offer?
Cell IDx offers Tissue Processors, Digital Pathology Scanners, and IHC Primary Antibodies.
Who are Cell IDx's investors?
Cell IDx has 1 investor. Key investors include Leica Biosystems.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.